Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic

J C Lorentzen1, S Issazadeh, M Storch

  • 1Department of Rheumatology; Karolinska Hospital, Karolinska Institute, Stockholm, Sweden.

Journal of Neuroimmunology
|December 31, 1995
PubMed

Insights

DA rats develop severe, protracted, and relapsing experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS). This demyelinating EAE model offers new insights into chronic neurological disease.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Experimental autoimmune encephalomyelitis (EAE) is a common animal model for multiple sclerosis (MS).
  • Traditional rat EAE models often exhibit acute, monophasic disease with minimal demyelination, unlike chronic, relapsing MS.
  • A need exists for EAE models that better recapitulate the chronic and demyelinating aspects of MS.

Purpose of the Study:

  • To establish and characterize a novel rat model of severe, protracted, and relapsing EAE (SPR-EAE).
  • To investigate the immunological and pathological features of this SPR-EAE model.
  • To assess the utility of this model for studying MS.

Main Methods:

  • Induction of EAE in DA rats via subcutaneous immunization with syngeneic spinal cord and incomplete Freund's adjuvant (IFA).
  • Assessment of neurological deficits, spinal cord pathology (demyelination, inflammation), and immune responses.
  • Evaluation of humoral and cellular autoreactivity to myelin antigens, including myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein (MBP) peptides.

Main Results:

  • DA rats developed severe, protracted, and relapsing EAE (SPR-EAE).
  • Neurological deficits correlated with demyelinating inflammatory lesions in the spinal cord, T lymphocyte infiltration, and immunoglobulin/complement deposition.
  • SPR-EAE induction involved humoral responses to MOG and cellular responses to MBP peptides (69-87, 87-101), which were encephalitogenic.

Conclusions:

  • The described demyelinating SPR-EAE in DA rats serves as a valuable preclinical model.
  • This model more closely mimics the chronic, relapsing, and demyelinating nature of multiple sclerosis.
  • Further research using this SPR-EAE model can advance understanding and treatment strategies for MS.

Related Concept Videos